Coulter Partners was delighted to partner recently with Azitra Inc. and secure the appointment of Mark Sampson, Ph.D. as their Chief Scientific Officer. Azitra is a clinical-stage medical dermatology company addressing severe skin conditions by harnessing the microbiome and has just announced that it has closed a $14 million Series A financing, led by KdT Ventures in conjunction with existing investor Bios Partners. 
EVENTS
23 October
2019
Join us for the Boardroom Ready Program in October, where Coulter Partners' Client Partner, Nona Footz will be presenting. Executive Women In Bio (EWIB) champions for greater diversity and is committed to supporting female leadership through professional development programs.
Edward Hæggström, CEO of Nanoform said: “It gives me great pleasure to welcome Mads Laustsen to the Nanoform board. Mads is an exceptional entrepreneur with vast experience in the provision of GMP facilities and infrastructures. His outstanding experience will be incredibly valuable as we expand our manufacturing capacity and I thank the highly professional team at Coulter Partners for helping us once more to achieve such a quality appointment.”EVENTS
30 October - 1 November
2019
Meet us at the annual AusBiotech conference, bringing together Australian and International biotech leaders and stakeholders in a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.
A selection of senior appointments during Quarter 2, 2019 across EMEA for growth companies and VCs. Industry segments this quarter included Digital Health, CNS, Healthcare Services, Immuno-oncology, Cell Therapy, Diagnostics, Regenerative Medicine, Ophthalmology and Vaccines.EVENTS
2 November - 6 November
2019
Join us and more than 5000 global healthcare leaders at ISPOR Europe 2019 in Copenhagen, Denmark – an energizing meeting ground for sound science, robust methodology, relevant policy discussions, and multi-stakeholder perspectives.
On June 25, Coulter Partners hosted around 200 guests for a sparkling Summer Party in the beautiful gardens of the Walks, Gray’s Inn, London. International clients and colleagues joined the London team in the big marquee to celebrate a fabulous year!EVENTS
11 November - 12 November
2019
Join us in London for the FT's gathering of the Life Sciences industry. Just one of the topics on day 1 will be "Turning the Big Pharma Ship - Transformation and Talent Strategies". We look forward to seeing you and exploring this topic and others that may be close to your heart.
EVENTS
11 November - 13 November
2019
Join us for BIO-Europe 2019 in Hamburg. As Europe's largest life science partnering conference, BIO-Europe offers countless opportunities to engage with global life science partners. Empower yourself with knowledge from key biotech and pharma leaders who will discuss the latest industry trends in workshops and panels.
EVENTS
13 November - 14 November
2019
Join us in London for DigiHealth Leaders, an impactful conference, showcase and insight platform from LSX - devoted to advancing digital health technologies through international investment, partnership and knowledge exchange.
“We are pleased that Ms. Beelen has joined Incysus at this key phase of development and thank the team at Coulter Partners for their outstanding professional support in achieving this appointment,” said William Ho, Chief Executive Officer of Incysus. “Melissa’s more than two decades of experience in drug development and clinical research will be invaluable as we take the next steps to develop commercially viable and effective allogeneic cellular immunotherapies for the treatment of cancer.”EVENTS
14 November
2019
Join us and the AESC for Create the Future. As we look to the future, where will we find the talent who can not only navigate a tomorrow we can only just imagine, but who can also build it? How will we deploy future talent to thrive in a climate of rapid technological advancement and massive societal change? How will we activate the disruptors with the vision and courage to create the future of innovation?
In April Samantha Bower and Mat Rosso, two of Coulter Partners’ Pittsburgh team, ran far from home in their first London Marathon in aid of London based charity, Kith and Kids. Samantha came home in a truly athletic 2 hours and 57 minutes and was the 81st woman to cross the line!!! In his first ever marathon, former US professional figure skater, Mat completed the race in 4 hours and 40 minutes.EVENTS
13 January - 15 January
2020
OxStem Co-Founder, Director and Waynflete Professor of Chemistry at the University of Oxford, Professor Steve Davies, said: “On behalf of the Board, Founders and management team, we warmly welcome Dr Stuart Collinson to OxStem and I thank the team at Coulter Partners for their outstanding professional support in achieving this appointment. Stuart is a highly experienced international business leader who brings significant fundraising, product development, partnering and commercialisation experience. We look forward to working with him to develop transformative medicines for patients suffering from severe degenerative diseases."
Global Life Sciences search specialist, Coulter Partners is pleased to announce the opening of a new office in Paris and another 14 appointments worldwide, during an extremely successful year which has seen group sales grow by 31%. Business in the US has grown by 165% since last year and this region now accounts for 45% of group sales.
“We were delighted to work once more with Coulter Partners to identify Christa and bring her into Pivot Bio. Her experience is a great addition to our already strong leadership team,” said Karsten Temme, CEO and co-founder, Pivot Bio. “Christa will play a key role in Pivot’s growth as we expand the technology to new markets.”
Dr John Ford, CEO, Enterprise Therapeutics, said: “We are delighted that Amit has chosen to join as Chairman at this exciting time for the Company, as we prepare to take our two lead programmes into the clinic in the next 12 months. Amit brings a wealth of experience in product development, portfolio management and commercial strategy in both the US and EU that will be critical in driving the Company through the next phase of its development. I would like to thank the team at Coulter Partners for their outstanding professional support in achieving this high calibre appointment.”
“We are very pleased to welcome Carla to AniCura. Her profound experience of building a strong healthcare group with efficient support to individual clinics will be key to developing AniCura, as we have now grown to become a leading veterinary care provider with more than 1,200 employees in the region. I would also like to express my sincere thanks to the team at Coulter Partners for their outstanding professional support in achieving this high calibre appointment,” says Øyvind Johnsen Brøgger, Group Operations Director at AniCura.
As a member of the Association of Executive Search and Leadership Consultants, Coulter Partners is proud to commit to a Code of Professional Practice. This video explains the value the AESC brings to our profession.
Coulter Partners was very pleased to partner with ArunA Bio, a leader in the development of exosomes for the treatment of CNS and neurodegenerative disorders, to secure the appointment of Mark Sirgo, Pharm.D. as Chief Executive Officer. Dr. Sirgo joins the company with more than 35 years of pharmaceutical industry experience and is most recognized for building the fully integrated pharmaceutical company, BioDelivery Sciences International (Nasdaq: BDSI).
Coulter Partners is delighted to announce that Senior Consultant, Zdenka Vitkova has been honoured with the AESC Future of the Profession Award. Designed to engage the next generation of leaders in executive search and leadership consulting, this prestigious award honours innovation and leadership and applies to professionals earlier in their career.